about
Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosisBARD1 expression during spermatogenesis is associated with apoptosis and hormonally regulatedIdentification of an apoptotic cleavage product of BARD1 as an autoantigen: a potential factor in the antitumoral response mediated by apoptotic bodies.Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival.Potential deleterious role of anti-Neu5Gc antibodies in xenotransplantation.Sialylation of antibodies in kidney recipients with de novo donor specific antibody, with or without antibody mediated rejection.Increased expression of inducible HSP70 in apoptotic cells is correlated with their efficacy for antitumor vaccine therapy.Production and characterisation of a monoclonal antibody specific for apoptotic bodies derived from several tumour cell lines.Apoptosis induced by sodium butyrate treatment increases immunogenicity of a rat colon tumor cell line.Upmodulation of alpha v beta 1 integrin expression on human tumor cells by human interleukin for DA cells/leukemia inhibitory factor and oncostatin M: correlation with increased cell adhesion on fibronectin.Human interleukin for DA cells/leukemia inhibitory factor and oncostatin M enhance membrane expression of intercellular adhesion molecule-1 on melanoma cells but not the shedding of its soluble form.Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens.Structural differences between plasma-membrane 5'-nucleotidase in different cell types as evidenced by antibodies.Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins.Nuclear-cytoplasmic translocation of BARD1 is linked to its apoptotic activity.Assignment of the BRCA1-associated RING domain gene (Bard1) to rat chromosome 9q34 by in situ hybridization and radiation hybrid mapping.Biomarkers for the diagnosis of the stable kidney transplant and chronic transplant injury using the ProtoArray® technology.[Modulation of integrin alpha-v-beta-1 expression on human tumor cells by leukemia inhibitory factor (LIF) and oncostatin M (OSM)]Asymmetrical orientation of phospholipids and their interactions with marker enzymes in pig heart mitochondrial inner membrane.Modulation of extracellular matrix glycoproteins production by in vitro interacting conditions between rat colonic fibroblasts and tumoral cellsLectin binding to serum 5'-nucleotidase and alkaline phosphatase in liver diseaseDifferences in the release of 5'-nucleotidase and alkaline phosphatase from plasma membrane of several cell types by PI-PLCDifferences in glycosylation state of fibronectin from two rat colon carcinoma cell lines in relation to tumoral progressivenessPurification of bovine liver cytosolic 5'-nucleotidase. Kinetic and structural studies as compared to the membrane isoenzymeChemical modification of essential carboxyl group and histidine residue in the plasma-membrane 5'-nucleotidasePurification and properties of bovine liver plasma membrane 5' nucleotidase5'-Nucleotidase from bovine caudate nucleus synaptic plasma membranes: specificity for substrates and cations; study of the carbohydrate moiety by glycosidasesEvidence for a metalloprotein structure of plasma membrane 5'-nucleotidase[Identification of spermatozoa L-selectin and two potential pellucida ligands]Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastasesAutoimmune responses against renal tissue proteins in long-term surviving allograft recipientsThe natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases
P50
Q28214712-07DEA422-913E-4DB4-99D0-D8FCBCD1D7C0Q28581513-B9A1381E-B195-4D65-BA80-B10FFE2E2C87Q30649037-CADDB086-2E24-4FDA-A853-14CF30DC4568Q36335918-7BB041B6-039B-41C6-ADFA-CDE73C898B44Q38259474-43D1247D-777F-4B2D-A27F-289120A6B421Q40345972-DB5F523C-8C09-46B4-8479-3B3464939167Q40498268-65331825-A89B-447B-9DA1-8897535D3CB3Q40918974-FAA264DE-E703-4722-B8BC-D0DCA304AD27Q41135519-8D6D4B1E-2ABA-43E8-A81B-6CC357FFB7C7Q41331294-5459C67B-0EE0-4814-90FB-67EEB8FC4C97Q41374791-31BA483B-0260-4A8B-8BBF-22AC84E99A6FQ41924097-7ABE2172-7F7B-40A0-B502-70B60CEB815BQ42867242-433B9E13-9912-42BD-849E-C4211ED2491BQ47132349-48598E3A-6F71-4220-83C1-A21ED484A5AEQ47784789-F7EA2078-2F04-4C90-9963-1BBA173E0FE1Q48317207-7555FE6F-221E-4BA3-A34C-455AB1B69CFFQ53288032-B0EF682F-8204-4C20-84F4-08AE715CC5AFQ61978481-B45B3C39-120C-4A6F-B00E-B0193E4F05A9Q64929090-24801AF0-5C55-4D8B-9F84-B74F57DDDFC8Q67467996-B8D272CC-E960-4EDD-8A04-1D528472F9C1Q68076413-1674857A-BE77-4AAC-9C20-4C91D659FD01Q69353756-6CC76F8F-4EF0-4B49-AEDC-D9ED35063667Q69694638-B5D4F38B-82C4-4142-8963-AE6B7B768100Q69820181-435E0296-A696-4020-BD07-F7919DD83DADQ69878613-4BD54921-EB4D-4EFB-9636-25232AC50113Q70179885-D6C54BFC-E522-4E99-B986-A4E7EE0EB985Q70192220-9E03577A-ABA0-416A-892D-EB7A567DEE49Q70212855-6A9E7D6C-5FB8-44E6-BB36-F2C548A1EBD4Q71799676-4B1FFFA6-09E4-4FD9-B277-D7C71FEA7CB5Q71900132-4DFB7C00-34AB-4294-8BC2-DBA8CAA34B56Q84275606-34CD4DB8-F877-4666-845A-EE08232A2CD3Q84968392-A4E6AA8F-61C7-4FBF-AA74-B36E0FCB6962
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jean Harb
@ast
Jean Harb
@en
Jean Harb
@es
Jean Harb
@nl
type
label
Jean Harb
@ast
Jean Harb
@en
Jean Harb
@es
Jean Harb
@nl
prefLabel
Jean Harb
@ast
Jean Harb
@en
Jean Harb
@es
Jean Harb
@nl
P106
P31
P496
0000-0002-1727-8610